Pelvic relapses in ovarian cancer. Role of CA-125, transvaginal ultrasound and color Doppler.
Eur J Gynaecol Oncol
; 24(3-4): 269-70, 2003.
Article
en En
| MEDLINE
| ID: mdl-12807237
ABSTRACT
From January 1995 to January 2001, 40 patients with epithelial ovarian cancer were treated at our Institution. Fourteen of these, with a clinical CR after surgery and platinum-based chemotherapy, were evaluated monthly by gynecological examination, Ca-125 RIA assay, pelvic ultrasound with transabdominal and transvaginal probe and color Doppler. Six pelvic relapses, from 1.5 to 3.0 cm, were detected by transvaginal ultrasound (US). They showed a rich neovascularization with low resistance, high flow, PI from 0.3 to 1.0 and RI < 0.5 in all cases. US did not reveal any sign of relapse in the remaining eight patients. In all cases of pelvic relapses ultrasonic signs of recurrence preceded the increase of Ca-125 by one to six months (average 3.8).
Buscar en Google
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Neoplasias Pélvicas
/
Biomarcadores de Tumor
/
Ultrasonografía Doppler en Color
/
Antígeno Ca-125
/
Endosonografía
/
Recurrencia Local de Neoplasia
Tipo de estudio:
Diagnostic_studies
/
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Aged
/
Female
/
Humans
/
Middle aged
País/Región como asunto:
Europa
Idioma:
En
Revista:
Eur J Gynaecol Oncol
Año:
2003
Tipo del documento:
Article
País de afiliación:
Italia